31.60 USD
▲+0.52+3.47%
盘后 30.54 0.00%
2026-08-03
市值
$1.89B
市盈率
—
EPS
-7.01
股息率
—
52 周区间
22.24 – 46.00
成交量
1.05M
Beta
0.58
目标价
45.38
52W 低 22.2452W 高 46.00
价格走势
公司简介
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company’s PYRUKYND product is also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatric patients; and AQVESME for the treatment of a...